Evidence map›Paper›PMID 33644545›Full record

ArticleACS omega2021

Effect of Charge Distribution in a Modified tRNA Substrate on Pre-Reaction Protein-tRNA Complex Geometry.

Alexey Rayevsky, Mohsen Sharifi, Eugeniy Demianenko, Dmitriy Volochnyuk, Michael Tukalo

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Alexey RayevskyDepartment of Protein Synthesis Enzymology, Institute of Molecular Biology and Genetics National Academy of Sciences of Ukraine, Osipovskogo st. 2a, Kyiv, UA 03143, Ukraine.
Mohsen SharifiRockGen Therapeutics, #831 Bioventure, 4301 W. Markham St., Little Rock, Arkansas 72205, United States.
Eugeniy DemianenkoChuiko Institute of Surface Chemistry of National Academy of Sciences of Ukraine, 17 General Naumov Str., Kyiv 03164, Ukraine.
Dmitriy VolochnyukDepartment of Biologically Active Compounds, Institute of Organic Chemistry NASU, Murmanskaya 5 str, Kyiv, 02660, Ukraine.
Michael TukaloDepartment of Protein Synthesis Enzymology, Institute of Molecular Biology and Genetics National Academy of Sciences of Ukraine, Osipovskogo st. 2a, Kyiv, UA 03143, Ukraine.
National Academy of Sciences of Ukraine · UAInstitute of Organic Chemistry · UANewGen Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An important aspect of molecular mechanics simulations of a protein structure and ligand binding often involves the generation of reliable force fields for nonstandard residues and ligands. We consider the aminoacyl-tRNA synthetase (AaRS) system that involves nucleic acid and amino acid derivatives, obtaining force field atomic charges using the restrained electrostatic potential (RESP) approach. These charges are shown to predict observed properties of the post-transfer editing reaction in this system, in contrast to simulations performed using approximate charges conceived based upon standard charges for related systems present in force field databases. In particular, the simulations predicted key properties induced by mutation. The approach taken for generating the RESP charges retains established charges for known fragments, defining new charges only for the novel chemical features present in the modified residues. This approach is of general relevance for the design of force fields for pharmacological applications, and indeed the AaRS target system is itself relevant to antibiotics development.

Identifiers

PMID33644545
PMCPMC7906584
OpenAlexW3127989128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.